Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Eyantra Ventures Ltd

EY
BSE
764.75
0.81%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Eyantra Ventures Ltd

EY
BSE
764.75
0.81%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
153Cr
Close
Close Price
764.75
Industry
Industry
Trading
PE
Price To Earnings
PS
Price To Sales
2.00
Revenue
Revenue
77Cr
Rev Gr TTM
Revenue Growth TTM
144.21%
PAT Gr TTM
PAT Growth TTM
-868.15%
Peer Comparison
How does EY stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
EY
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
36768118202326
Growth YoY
Revenue Growth YoY%
196.188.519.4229.3200.4133.6
Expenses
ExpensesCr
25657118222629
Operating Profit
Operating ProfitCr
0101100-2-3-2
OPM
OPM%
7.014.75.815.28.44.00.0-10.8-14.1-8.9
Other Income
Other IncomeCr
0000000000
Interest Expense
Interest ExpenseCr
0000000000
Depreciation
DepreciationCr
0000000111
PBT
PBTCr
010110-1-3-4-4
Tax
TaxCr
0000000000
PAT
PATCr
010100-1-3-4-4
Growth YoY
PAT Growth YoY%
183.3-82.0-273.3-518.3-1,402.9-3,445.4
NPM
NPM%
4.710.24.613.84.51.0-6.7-17.5-19.3-13.9
EPS
EPS
0.83.91.84.51.90.6-2.8-8.6-12.0-10.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025TTM
Revenue
RevenueCr
173377
Growth
Revenue Growth%
95.1134.6
Expenses
ExpensesCr
153184
Operating Profit
Operating ProfitCr
12-8
OPM
OPM%
8.96.1-10.0
Other Income
Other IncomeCr
000
Interest Expense
Interest ExpenseCr
001
Depreciation
DepreciationCr
003
PBT
PBTCr
21-12
Tax
TaxCr
010
PAT
PATCr
11-12
Growth
PAT Growth%
-29.5-1,706.5
NPM
NPM%
6.32.3-15.7
EPS
EPS
6.44.0-33.5

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
222
Reserves
ReservesCr
102626
Current Liabilities
Current LiabilitiesCr
2223
Non Current Liabilities
Non Current LiabilitiesCr
0111
Total Liabilities
Total LiabilitiesCr
143160
Current Assets
Current AssetsCr
102132
Non Current Assets
Non Current AssetsCr
41027
Total Assets
Total AssetsCr
143160

Cash Flow

Consolidated
Standalone
Financial YearMar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
-1-1
Investing Cash Flow
Investing Cash FlowCr
-4-15
Financing Cash Flow
Financing Cash FlowCr
515
Net Cash Flow
Net Cash FlowCr
1-1
Free Cash Flow
Free Cash FlowCr
-1-1
CFO To PAT
CFO To PAT%
-52.6-140.3
CFO To EBITDA
CFO To EBITDA%
-37.6-52.6

Ratios

Consolidated
Standalone
Financial YearMar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
175229
Price To Earnings
Price To Earnings
164.8304.8
Price To Sales
Price To Sales
10.57.0
Price To Book
Price To Book
14.38.2
EV To EBITDA
EV To EBITDA
114.3108.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
36.743.8
OPM
OPM%
8.96.1
NPM
NPM%
6.32.3
ROCE
ROCE%
12.34.9
ROE
ROE%
8.72.7
ROA
ROA%
7.62.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
**Eyantra Ventures Limited** (formerly Punit Commercials Limited) is a diversified Indian conglomerate that has undergone a radical strategic transformation. Following a management change in **2022**, the company pivoted from diamond trading to a high-growth multi-vertical model. Today, Eyantra operates at the intersection of **IT Services, Corporate Merchandising, and Healthcare**, leveraging a debt-free balance sheet and aggressive inorganic growth to scale both domestically and internationally. --- ### **Strategic Business Verticals & Revenue Streams** The company’s revenue is generated through five primary activities, with a strategic shift toward digital platforms and high-margin technology services. | Vertical | Core Focus & Operations | Key Platforms/Assets | | :--- | :--- | :--- | | **Merchandising** | B2B custom merchandise and curated corporate gifting. Transitioned from on-demand fulfillment to a pre-discovery digital model. | **shop.eyantra.com**, **Hamper Story** | | **IT Services** | AI security, cloud transformation, and digital engineering for US and European markets. | **Prismberry Technologies** | | **Healthcare** | Specialized neuro and spine hospital services and pharmacy product sales. | **Neuro and Spine Associates (NASAPL)** | | **Software Services** | Development of RBI-aligned fintech platforms, payments, and Prepaid Instrument (PPI) systems. | Internal IP | | **Other Services** | Miscellaneous service-linked revenue lines and consulting. | N/A | --- ### **Technology Capabilities: AI, IoT, and Embedded Systems** Eyantra provides a dual-core service offering designed to bridge the gap between hardware and software, facilitating digital transformation through connected ecosystems. * **Transformative Software Services:** Focuses on enterprise growth through **Artificial Intelligence (AI)**, custom software engineering, and mobile application development. * **Embedded and IoT Solutions:** End-to-end support for device connectivity, ranging from **Innovative Product Design** to the implementation of **Embedded Hardware** and **Internet of Things (IoT)** ecosystems. * **Fintech Integration:** The leadership possesses specialized expertise in obtaining **RBI in-principle approval** for Prepaid Payment Instruments (**PPI**). The company is currently among the largest issuers of **prepaid cards** in India within its specific niche. --- ### **Global Footprint & Subsidiary Structure** The group has expanded its operational reach through strategic acquisitions and international incorporations to diversify geographic risk. | Entity Name | Relationship | Purpose & Status | | :--- | :--- | :--- | | **Prismberry Technologies Pvt Ltd** | **100%** Subsidiary | Acquired **Aug 2023** for **₹4.20 Cr**; serves as the primary IT delivery engine. | | **Neuro and Spine Associates Pvt Ltd** | **60%** Subsidiary | Healthcare provider; **₹10.8 Cr** invested for **51.92%** stake as of **June 2025**. | | **Eyantra Ventures FZE (UAE)** | **100%** Subsidiary | Incorporated **July 2024** in Ajman Free Zone to serve the Middle East. | | **Eyantra Ventures Inc (USA)** | **100%** Subsidiary | Incorporated **May 2025** in Delaware; hub for international IT and US operations. | --- ### **Financial Trajectory & Capital Efficiency** Eyantra has demonstrated explosive top-line growth while maintaining a conservative, **debt-free** capital structure. #### **Comparative Financial Performance** | Metric (INR in Lakhs/Crores) | FY 2024-25 (Est.) | FY 2023-24 (Consol.) | FY 2022-23 (Stand.) | | :--- | :--- | :--- | :--- | | **Total Revenue** | **₹27.59 Cr** | **₹16.76 Cr** | **₹4.97 Cr** | | **Revenue Growth (YoY)** | **~96%** | **183%** | **214%** | | **Profit After Tax (PAT)** | *TBD* | **₹0.745 Cr** | **₹0.525 Cr** | | **Debt-to-Equity Ratio** | **0.00** | **0.00** | **0.00** | | **Current Ratio** | **10.49x** | *N/A* | *N/A* | #### **Revenue Segmentation (FY 2023-24)** * **Merchandise:** **₹1,120.31 Lakhs** (Largest contributor) * **Services:** **₹555.80 Lakhs** * **Domestic (India):** **₹1,403.03 Lakhs** * **International:** **₹273.09 Lakhs** --- ### **Capital Structure & Fundraising Strategy** The company aggressively utilizes preferential allotments to fund its inorganic growth and working capital requirements without taking on debt. * **Preferential Allotment (Jan 2025):** Allotted **1,87,500** shares at **₹800** per share (Total: **₹15 Crore**). * **Fundraising Plan (Nov 2024):** Approved issuance of up to **3,38,343** shares at **₹800** to raise **₹27.07 Crore**. * **Acquisition Funding (Aug 2023):** Issued **1,75,000** shares via share swap for the **Prismberry** acquisition and **2,04,375** shares at **₹240** for cash. * **Paid-up Capital:** Stood at **₹2.00 Crore** (divided into **20,06,875** equity shares) as of March 31, 2025. * **Asset Valuation:** A 2025 third-party valuation of **Prismberry Technologies** at **₹6.21 Crore** (vs. **₹4.2 Crore** book value) resulted in **zero impairment loss** recognized. --- ### **Growth Strategy & Future Outlook** Eyantra’s roadmap focuses on scaling existing capacities and deepening market penetration: * **Merchandising Expansion:** Target to increase product listings on **shop.eyantra.com** from **200+** to **1,000+**; deepening presence in **Bangalore, Mumbai, NCR, and Hyderabad**. * **Healthcare Scaling:** Currently operating **300 beds** across **3** centers; plans to launch a **4th center** (**60-100 beds**) and evaluating further acquisitions in Southern India. * **Talent Retention:** Launched **EYANTRA ESOP 2025** with a pool of **2,00,000** options to align employee interests with long-term corporate performance. * **Governance:** The Board maintains **50% independent representation** with expertise spanning banking, finance, and technology. **Mrs. Vinita Raj Narayanam** leads as MD through **2028**. --- ### **Risk Management & Mitigation** The company operates under a formal Risk Management Policy in compliance with the **Companies Act, 2013** and **SEBI (LODR)**. | Risk Category | Mitigation Strategy | | :--- | :--- | | **Credit Risk** | Managed via **Expected Credit Loss (ECL)** models and rigorous counterparty creditworthiness checks. | | **Liquidity Risk** | Maintained through a high **Current Ratio (10.49x)** and access to non-fund-based working capital limits. | | **Market & Interest Risk** | Monitored by the Audit Committee; currently has **zero exposure** to floating rate interest-bearing debt. | | **Cyber Security** | Integrated into the IT services framework, particularly for fintech and AI operations. | | **Exchange Rate Risk** | Reported as **zero** for the current period, though this may change as US/UAE operations scale. |